These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7607606)

  • 1. Lack of correlation between levels of osteocalcin and bone alkaline phosphatase in healthy control and postmenopausal osteoporotic women.
    Díaz Diego EM; Díaz Martín MA; de la Piedra C; Rapado A
    Horm Metab Res; 1995 Mar; 27(3):151-4. PubMed ID: 7607606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis.
    Takahashi M; Kushida K; Hoshino H; Miura M; Ohishi T; Inoue T
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):177-83. PubMed ID: 9302392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone formation in the study of postmenopausal osteoporosis.
    Dominguez Cabrera C; Sosa Henríquez M; Traba ML; Alvarez Villafañe E; de la Piedra C
    Osteoporos Int; 1998; 8(2):147-51. PubMed ID: 9666938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ; Wolfert RL; Hill CS
    Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone alkaline phosphatase measured with a new immunoradiometric assay in patients with metabolic bone diseases.
    Gonnelli S; Cepollaro C; Montagnani A; Monaci G; Campagna MS; Franci MB; Gennari C
    Eur J Clin Invest; 1996 May; 26(5):391-6. PubMed ID: 8796366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive osteocalcin forms in conditioned media from human osteoblast culture and in sera from healthy adult control subjects and patients with bone pathologies.
    Diaz Diego EM; Nacher M; Rapado A; Serrano S; Bosch J; Aubia J; de la Piedra C
    Eur J Clin Invest; 1998 Jan; 28(1):48-58. PubMed ID: 9502187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies.
    Azinge EC; Bolarin DM
    Niger J Physiol Sci; 2006; 21(1-2):21-5. PubMed ID: 17242729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects.
    Catherwood BD; Marcus R; Madvig P; Cheung AK
    Bone; 1985; 6(1):9-13. PubMed ID: 3873250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.
    Bruyere O; Collette J; Delmas P; Rouillon A; Roux C; Seidel L; Richy F; Reginster JY
    Maturitas; 2003 Apr; 44(4):259-65. PubMed ID: 12697366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients.
    Body JJ; Dumon JC; Blocklet D; Darte C
    Eur J Cancer; 1997 Sep; 33(10):1578-82. PubMed ID: 9389918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
    Cao Y; Liu X; Xu H
    Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BGP (osteocalcin, bone-Gla-protein) in involutional osteoporosis.
    Rapado A; de la Piedra C; Torres R
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():30-4. PubMed ID: 2788062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
    Sartorio A; Conti A; Monzani M
    Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A variation in Bone Alkaline Phosphatase levels that correlates positively with bone loss and normal levels of aminoterminal propeptide of collagen I in girls with anorexia nervosa.
    Calero JA; Muñoz MT; Argente J; Traba ML; Méndez-Dávila C; García-Moreno C; de la Piedra C
    Clin Chim Acta; 1999 Jul; 285(1-2):121-9. PubMed ID: 10481928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study on bone loss rate in early and late stages of post-menopausal women].
    Xu H; Wu Y; Yan Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):542-5. PubMed ID: 10806731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.
    Watts NB; Jenkins DK; Visor JM; Casal DC; Geusens P
    Osteoporos Int; 2001; 12(4):279-88. PubMed ID: 11420777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in serum bone GLA protein with age and sex.
    Epstein S; Poser J; McClintock R; Johnston CC; Bryce G; Hui S
    Lancet; 1984 Feb; 1(8372):307-10. PubMed ID: 6141381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.